EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Beyond BMI: Surgical Readiness in the Age of GLP-1 Therapy

Thomas Meade, MD, Reza Jazayeri

Journal of Orthopaedic Experience & Innovation · 17.10.2026 · 7 (2)

DOI: 10.60118/001c.164818 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Orthopaedic Experience & Innovation, online erschienen am 17.10.2026. Verfasst von Thomas Meade und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

GLP-1 receptor agonists like Ozempic and Wegovy are reshaping how healthcare systems approach preoperative optimization. Originally developed for diabetes, these therapies are now widely used for weight reduction. In orthopedics, this shift is transforming patient preparation for major surgeries like Total Knee Arthroplasty (TKA).

Zitieren

APA

Meade, T., MD, & Jazayeri, R. (2026). Beyond BMI: Surgical Readiness in the Age of GLP-1 Therapy. Journal of Orthopaedic Experience & Innovation, 7(2). https://doi.org/10.60118/001c.164818

Vancouver

Meade T, MD, Jazayeri R. Beyond BMI: Surgical Readiness in the Age of GLP-1 Therapy. Journal of Orthopaedic Experience & Innovation. 2026;7(2). doi:10.60118/001c.164818

BibTeX
@article{Meade2026,
  author = {Meade, Thomas and MD and Jazayeri, Reza},
  title = {Beyond BMI: Surgical Readiness in the Age of GLP-1 Therapy},
  journal = {Journal of Orthopaedic Experience & Innovation},
  year = {2026},
  volume = {7},
  number = {2},
  doi = {10.60118/001c.164818}
}
Kostenlos starten →